💨 Abstract
The article contains two distinct sections with different topics. Here's a summary of each: 1. **Precision BioSciences Inc. Financial Report**: - The genome editing company reported a loss of $20.6 million in the first quarter of 2025. - Loss per share was $2.21. - Revenue for the period was $29,000.
Courtesy: wtop.com
Suggested
La Fed advierte sobre una inflación más volátil: datos muestran impacto de los aranceles en los precios mayoristas -
Affiliated baseball may soon return to Frederick -
Recta final: Jueves de Nominación tras 100 días de convivencia y traiciones
Sean ‘Diddy’ Combs’ lawyers plan to press Cassie about infidelity during cross-examination -
Ideal Power: Q1 Earnings Snapshot -
45% more people rejected at German border after checks were stepped up, minister says -
Security National Financial: Q1 Earnings Snapshot -
Agentes inmobiliarios destacan que “la estabilización de los procesos de especulación aceleraron los cierres de operaciones” -
Stratus Properties: Q1 Earnings Snapshot -
Atara Biotherapeutics: Q1 Earnings Snapshot -